|
|
Volumn 88, Issue 2, 2008, Pages 109-111
|
|
Gatifloxacin
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FENBUFEN;
GATIFLOXACIN;
ISONIAZID;
LEVOFLOXACIN;
MOXIFLOXACIN;
OFLOXACIN;
RIFAMPICIN;
SPARFLOXACIN;
AMES TEST;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTHROPATHY;
BACTERICIDAL ACTIVITY;
CARDIOTOXICITY;
CHROMOSOME ANALYSIS;
DIARRHEA;
DIZZINESS;
DRUG ABSORPTION;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
DRUG SAFETY;
DRUG SOLUBILITY;
DRUG TARGETING;
DRUG TOLERABILITY;
FETOTOXICITY;
GENE MUTATION;
HEADACHE;
HUMAN;
HYPOGLYCEMIA;
IN VITRO STUDY;
IN VIVO STUDY;
LIVER FAILURE;
LIVER TOXICITY;
MONOTHERAPY;
MOUSE;
MYCOBACTERIUM TUBERCULOSIS;
NAUSEA;
NONHUMAN;
ORGANOGENESIS;
PHOTOTOXICITY;
PRIORITY JOURNAL;
RAT;
REVIEW;
RISK FACTOR;
SEIZURE;
SINGLE DRUG DOSE;
SKELETON MALFORMATION;
TENDINITIS;
TUBERCULOSIS;
ANIMALS;
ANTITUBERCULAR AGENTS;
FLUOROQUINOLONES;
HUMANS;
TREATMENT OUTCOME;
TUBERCULOSIS;
|
|
EID: 43249101361
PISSN: 14729792
EISSN: None
Source Type: Journal
DOI: 10.1016/S1472-9792(08)70010-6 Document Type: Review |
|
Times cited : (10)
|
|
References (9)
|
